MON1B inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of MON1B, a protein that plays a critical role in regulating intracellular membrane trafficking, particularly in endosomal maturation and vesicle transport. MON1B, in complex with CCZ1, is involved in the transition of early endosomes to late endosomes by recruiting and activating Rab7, a key GTPase that governs endosomal maturation and subsequent fusion with lysosomes. This process is essential for the proper sorting of proteins, lipids, and other cargo, as well as for maintaining cellular homeostasis through the degradation and recycling of cellular components. By inhibiting MON1B, researchers can disrupt these critical trafficking pathways, leading to impaired endosome-to-lysosome transport and the accumulation of undegraded materials in cells, thus providing a useful tool to study vesicular transport and its broader implications for cellular function.
In research contexts, MON1B inhibitors are valuable for investigating the molecular mechanisms that underlie endosomal maturation and the broader impact of disrupted vesicle trafficking on cellular processes such as autophagy, nutrient sensing, and organelle maintenance. By blocking MON1B activity, scientists can explore how the inhibition affects endosome-lysosome fusion, cargo degradation, and the recycling of cellular components. This inhibition allows for the examination of how defects in these pathways can lead to cellular dysfunction, including altered metabolic signaling, impaired organelle function, and misregulation of cellular homeostasis. Additionally, MON1B inhibitors provide insights into the interactions between MON1B and other components of the endosomal sorting machinery, helping to elucidate the complex networks that regulate intracellular trafficking. Through these studies, the use of MON1B inhibitors enhances our understanding of the intricate processes involved in vesicle transport, endosome maturation, and the broader implications of these pathways for maintaining cellular health and functionality.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits PI3K, potentially altering vesicular trafficking and autophagy processes. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $87.00 | 44 | |
Inhibits dynamin, potentially affecting endocytosis and vesicular trafficking pathways. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Inhibits tyrosine kinases, potentially altering signaling pathways that regulate endosomal function. | ||||||
FCM Lysing solution (1x) | sc-3621 | 150 ml | $61.00 | 8 | ||
Raises lysosomal pH, potentially affecting lysosomal function and related protein trafficking. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Similar to NH4Cl, raises lysosomal pH, potentially affecting lysosomal degradation processes. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Specifically inhibits V-ATPase, potentially affecting acidification of organelles and protein sorting. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
Disrupts Golgi function, potentially affecting glycosylation and trafficking of proteins. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
Disrupts microtubule polymerization, potentially affecting vesicular transport processes. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $145.00 $442.00 | 64 | |
Inhibits actin polymerization, potentially affecting cytoskeleton-dependent transport and signaling. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $134.00 $502.00 | 7 | |
Inhibits CDC42, potentially affecting actin organization and membrane trafficking. |